Table 1.
Characteristics of 13 patients with COVID-19
| Characteristics | Value |
|---|---|
| Age, mean (SD), years | 63 (12) |
| Male sex, No. (%) | 9 (69) |
| Body weight, mean (SD), kg | 70 (21) |
| Bronchial asthma No. (%) | 1 (8) |
| Diabetes mellitus, No. (%) | 7 (54) |
| Hypertension, No. (%) | 8 (62) |
| Sleep apnea syndrome, No. (%) | 3 (23) |
| APACHE II score, median [IQR] | 9 [5, 13] |
| PaO2/FIO2 ratio at intubation, mean (SD) | 210 (73) |
| D-dimer on admission, median [IQR], ng/mL | 1.3 [1.0, 2.8] |
| CRP on admission, median [IQR], mg/dL | 11.9 [4.6, 19.6] |
| PCT on admission, median [IQR], ng/mL | 0.21 [0.09, 0.54] |
| Presepsin on admission, median [IQR], pg/mL | 440 [302, 763] |
| IL-6 on admission, median [IQR], pg/mL | 77.5 [35.7, 161.9] |
| Time from first symptom appearance, mean (SD), day | |
| Favipiravir | 8.7 (2.6) |
| Heparin | 10.8 (3.9) |
| Steroid | 13.2 (2.9) |
| Dexmedetomidine | 10.7 (4.1) |
| Intubation | 9.9 (3.3) |
| ECMO, No. (%) | 1 (8) |
| Ventilator days, median [IQR], days | 11 [9, 12] |
| Outcome, No. (%) | |
| Survived | 12 (92) |
| Dead | 1 (8) |
SD standard deviation, APACHE II Acute Physiology and Chronic Health Evaluation II, IQR interquartile range, PaO2 arterial partial pressure of oxygen, FIO2 fraction of inspiratory oxygen, CRP C-reactive protein, PCT procalcitonin, IL-6 interleukin-6, ECMO extracorporeal membrane oxygenation
Continuous variables were reported as median [interquartile range] (IQR). Categorical variables were reported as numbers and percentages